AI Engineer at Clairo

Leuven, Flanders, Belgium

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, HealthcareIndustries

Requirements

Master’s or PhD in Computer Science, Biomedical Engineering, Physics, or related field (Bachelor’s with relevant experience also considered)
Minimum 3 years of experience in software development
Strong proficiency in Python and experience with ML frameworks (e.g., PyTorch)
Experience training, validating, and deploying AI models; LLM fine-tuning is a plus
Familiarity with AWS and Agile development environments
Creative problem-solving mindset and ability to adapt to changing priorities
Excellent communication, organizational, and interpersonal skills
Attention to detail and commitment to quality

Responsibilities

Design and develop AI-powered software solutions using GenAI and machine learning frameworks
Build and optimize data processing pipelines for model training and evaluation
Train and fine-tune AI models, including LLMs, for real-world applications
Implement testing strategies and performance benchmarks to ensure model reliability
Collaborate with cross-functional teams to align AI initiatives with business goals
Stay current with emerging trends in GenAI, AI research, and software development
Engage with scientific literature and contribute to innovation across the organization
Support internal teams by resolving technical issues and sharing best practices
Foster a collaborative and inclusive team environment

Skills

Python

PyTorch

Machine Learning

Generative AI

LLM fine-tuning

AWS

Agile

Data Pipelines

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free